Reuters logo
BRIEF-Aptose provides update on FDA clinical hold of APTO-253
2016年10月13日 / 上午11点22分 / 1 年前

BRIEF-Aptose provides update on FDA clinical hold of APTO-253

Oct 13 (Reuters) - Aptose Biosciences Inc :

* Aptose provides update on FDA clinical hold of APTO-253

* Aptose biosciences-FDA response focused exclusively on request to provide with complete CMC information on final GMP drug substance and drug product intended for clinic

* Generation of additional data requested by FDA is underway, and once available data will be submitted for FDA review Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below